Edition:
United Kingdom

People: 3D Systems Corp (DDD.N)

DDD.N on New York Stock Exchange

10.84USD
9:02pm BST
Change (% chg)

$-0.19 (-1.72%)
Prev Close
$11.03
Open
$10.94
Day's High
$10.98
Day's Low
$10.76
Volume
209,813
Avg. Vol
415,637
52-wk High
$21.76
52-wk Low
$9.00

Erickson, Thomas 

Mr. Thomas Willard Erickson is an Independent Director of the 3D Systems Corporation. Mr. Erickson has been President and Chief Executive Officer of ECG Ventures, Inc., an investment firm, since 1987. He has also served as Chairman of Western Dental Services, Inc., a dental services provider, from November 2012 to September 2015; Interim Chief Executive Officer of Western Dental Services, Inc. from April 2013 to January 2014, and Chairman of the Board of Inmar, Inc., a reverse logistics and revenue recovery company, from April 2010 to February 2014. Mr. Erickson has also previously served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm; Chairman and Interim President of National Medical Health Card Systems, Inc., a publicly traded pharmacy benefits manager; Chairman of the Board of PathWays, Inc., an operator of post-acute care facilities; Chairman of the Board of TransHealthcare, Inc., a health care services company; Chairman and Interim Chief Executive Officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals; Interim President and Chief Executive Officer of Luminex Corporation, a publicly traded biotechnology company; and Interim President and Chief Executive Officer of Omega Healthcare Investors, Inc., a publicly traded healthcare focused real estate investment trust. Mr. Erickson was also co-founder, President and Chief Executive Officer of CareSelect Group, Inc., a physician practice management company. Mr. Erickson is currently a Director of American Renal Associates and Luminex Corporation.

Basic Compensation

Total Annual Compensation, USD 176,000
Restricted Stock Award, USD 99,997
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 275,997

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles McClure

171,123

Vyomesh Joshi

1,933,110

John McMullen

807,968

Charles Hull

596,011

Kevin McAlea

697,104

Andrew Johnson

612,993
As Of  31 Dec 2017